Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to define the safety and efficacy of recombinant human
growth hormone (rh-GH, Genotropin) in a patients undergoing allogeneic transplantation.